Daniel Seeliger

Daniel Seeliger has a diverse work experience in the field of computational chemistry and drug design. Daniel is currently working at Exscientia as the Associate Vice President and Head of Small Molecule Design. Prior to this, they held the role of Executive Director of Computational Drug Design at Exscientia. Before joining Exscientia, Daniel worked at Boehringer Ingelheim, where they served as the Head of the Computational Chemistry Team and Director (ad interim) of Computational Chemistry. Daniel also worked as a Principal Scientist in Computational Chemistry and as a PostDoc in Computational Antibody Engineering at Boehringer Ingelheim. Daniel's earlier experience includes working as a PostDoc at the Max Planck Institute for Biophysical Chemistry.

Daniel Seeliger has a Dipl.-Chem. degree in Chemistry from Ulm University, which they obtained from 1998 to 2003. Daniel also holds a Dr. rer. nat. degree in Computational Biophysics from the Max-Planck-Institute for Biophysical Chemistry, which they obtained from 2004 to 2008.